Authors: | Razavi, P.; Ahmed, M.; Roush, A.; Parikh, R.; Hitchens, A.; Shen, S.; Safonov, A.; Jhaveri, K. L.; Robson, M. E.; Peacock, N. W.; Ma, Y.; Santarsiero, E. C.; Ganapathy, V.; Shah, R. M.; Amefule, A. Q.; Lteif, A.; Blakely, L. J. |
Abstract Title: | Real-world (RW) risk of recurrence among patients (pts) diagnosed with stage II-III HR+/HER2-early breast cancer (EBC) treated with endocrine therapy (ET) in the US |
Meeting Title: | 2024 ASCO Annual Meeting |
Journal Title: | Journal of Clinical Oncology |
Volume: | 42 |
Issue: | 16 Suppl. |
Meeting Dates: | 2024 May 31-Jun 4 |
Meeting Location: | Chicago, IL |
ISSN: | 0732-183X |
Publisher: | American Society of Clinical Oncology |
Date Published: | 2024-06-01 |
Language: | English |
ACCESSION: | WOS:001275557403004 |
PROVIDER: | wos |
DOI: | 10.1200/JCO.2024.42.16_suppl.e12533 |
Notes: | Meeting Abstract: e12533 -- Source: Wos |